☰

Dilja Krueger, Ph.D. - Publications

Affiliations: 
2007 Yale University, New Haven, CT 
Area:
Neuroscience Biology
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

7/18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 El-Kordi A, Winkler D, Hammerschmidt K, Kästner A, Krueger D, Ronnenberg A, Ritter C, Jatho J, Radyushkin K, Bourgeron T, Fischer J, Brose N, Ehrenreich H. Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism. Behavioural Brain Research. 251: 41-9. PMID 23183221 DOI: 10.1016/J.Bbr.2012.11.016  0.303
2011 Krueger DD, Osterweil EK, Chen SP, Tye LD, Bear MF. Cognitive dysfunction and prefrontal synaptic abnormalities in a mouse model of fragile X syndrome. Proceedings of the National Academy of Sciences of the United States of America. 108: 2587-92. PMID 21262808 DOI: 10.1073/Pnas.1013855108  0.336
2009 Krueger DD, Howell JL, Oo H, Olausson P, Taylor JR, Nairn AC. Prior chronic cocaine exposure in mice induces persistent alterations in cognitive function. Behavioural Pharmacology. 20: 695-704. PMID 19901826 DOI: 10.1097/FBP.0b013e328333a2bb  0.396
2007 Krueger DD, Nairn AC. Expression of PKC substrate proteins, GAP-43 and neurogranin, is downregulated by cAMP signaling and alterations in synaptic activity. The European Journal of Neuroscience. 26: 3043-53. PMID 18005072 DOI: 10.1111/j.1460-9568.2007.05901.x  0.411
2007 Olausson P, Jentsch JD, Krueger DD, Tronson NC, Nairn AC, Taylor JR. Orbitofrontal cortex and cognitive-motivational impairments in psychostimulant addiction: evidence from experiments in the non-human primate. Annals of the New York Academy of Sciences. 1121: 610-38. PMID 17698993 DOI: 10.1196/annals.1401.016  0.406
2007 Andrade EC, Krueger DD, Nairn AC. Recent advances in neuroproteomics. Current Opinion in Molecular Therapeutics. 9: 270-81. PMID 17608026  0.412
2006 Krueger DD, Howell JL, Hebert BF, Olausson P, Taylor JR, Nairn AC. Assessment of cognitive function in the heterozygous reeler mouse. Psychopharmacology. 189: 95-104. PMID 16977475 DOI: 10.1007/s00213-006-0530-0  0.384
Low-probability matches (unlikely to be authored by this person)
2013 Woo J, Kwon SK, Nam J, Choi S, Takahashi H, Krueger D, Park J, Lee Y, Bae JY, Lee D, Ko J, Kim H, Kim MH, Bae YC, Chang S, et al. The adhesion protein IgSF9b is coupled to neuroligin 2 via S-SCAM to promote inhibitory synapse development. The Journal of Cell Biology. 201: 929-44. PMID 23751499 DOI: 10.1083/Jcb.201209132  0.282
2014 Ju A, Hammerschmidt K, Tantra M, Krueger D, Brose N, Ehrenreich H. Juvenile manifestation of ultrasound communication deficits in the neuroligin-4 null mutant mouse model of autism. Behavioural Brain Research. 270: 159-64. PMID 24855039 DOI: 10.1016/J.Bbr.2014.05.019  0.276
2012 Krueger DD, Tuffy LP, Papadopoulos T, Brose N. The role of neurexins and neuroligins in the formation, maturation, and function of vertebrate synapses. Current Opinion in Neurobiology. 22: 412-22. PMID 22424845 DOI: 10.1016/J.Conb.2012.02.012  0.273
2011 Krueger DD, Bear MF. Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annual Review of Medicine. 62: 411-29. PMID 21090964 DOI: 10.1146/annurev-med-061109-134644  0.264
2014 Kong SW, Sahin M, Collins CD, Wertz MH, Campbell MG, Leech JD, Krueger D, Bear MF, Kunkel LM, Kohane IS. Divergent dysregulation of gene expression in murine models of fragile X syndrome and tuberous sclerosis. Molecular Autism. 5: 16. PMID 24564913 DOI: 10.1186/2040-2392-5-16  0.263
2015 Jedlicka P, Vnencak M, Krueger DD, Jungenitz T, Brose N, Schwarzacher SW. Neuroligin-1 regulates excitatory synaptic transmission, LTP and EPSP-spike coupling in the dentate gyrus in vivo. Brain Structure & Function. 220: 47-58. PMID 25713840 DOI: 10.1007/S00429-013-0636-1  0.255
2010 Osterweil EK, Krueger DD, Reinhold K, Bear MF. Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 15616-27. PMID 21084617 DOI: 10.1523/Jneurosci.3888-10.2010  0.243
2014 Kleijer KT, Schmeisser MJ, Krueger DD, Boeckers TM, Scheiffele P, Bourgeron T, Brose N, Burbach JP. Neurobiology of autism gene products: towards pathogenesis and drug targets. Psychopharmacology. 231: 1037-62. PMID 24419271 DOI: 10.1007/S00213-013-3403-3  0.242
2010 Krueger DD, Osterweil EK, Bear MF. Activation of mGluR5 induces rapid and long-lasting protein kinase D phosphorylation in hippocampal neurons. Journal of Molecular Neuroscience : Mn. 42: 1-8. PMID 20177824 DOI: 10.1007/S12031-010-9338-9  0.226
2013 Krueger DD, Brose N. Evidence for a common endocannabinoid-related pathomechanism in autism spectrum disorders. Neuron. 78: 408-10. PMID 23664608 DOI: 10.1016/j.neuron.2013.04.030  0.196
2004 Slager EH, van der Minne CE, Krüse M, Krueger DD, Griffioen M, Osanto S. Identification of multiple HLA-DR-restricted epitopes of the tumor-associated antigen CAMEL by CD4+ Th1/Th2 lymphocytes. Journal of Immunology (Baltimore, Md. : 1950). 172: 5095-102. PMID 15067093  0.057
Hide low-probability matches.